Table 1.

Characteristics at the time of renal transplantation of 296 patients with ADPKD and functional renal allografts according to the presence of native kidney or liver cyst infection during follow-up

Characteristics	Whole sample N = 296	Not available (missing)	Cyst infection n = 21	No cyst infection n = 275
Recipient characteristics
Age – yr	60 (8)	0	63 (4)	56 (10)
Male	157 (53%)	0	10 (48%)	147 (53%)
History of diabetes	27 (9%)	0	4 (19%)	23 (8%)
History of cardiovascular disease	107 (36%)	0	8 (38%)	99 (36%)
History of nephrectomy (uni- or bilateral)	46 (16%)	0	3 (14%)	43 (16%)
History of cyst infection	43 (15%)	0	7 (33%)	36 (13%)
BMI (kg/m2)	26 (4)	0	26 (4)	26 (2)
HLA sensitization class I	107 (40%)	26	7 (41%)	100 (40%)
HLA sensitization class II	84 (31%)	26	3 (19%)	81 (32%)
Donor characteristics
Living donor	61 (21%)	0	6 (29%)	55 (19%)
Deceased donor	235 (79%)	0	15 (71%)	220 (80%)
Expanded criteria donor	126 (43%)	0	10 (48%)	116 (42%)
Transplantation characteristics
Retransplantation	37 (13%)	0	0 (0%)	37 (13%)
Pre-emptive transplantation	114 (39%)	0	10 (48%)	104 (38%)
Cold ischemia (hours)	12 (8)	0	13 (9)	12 (7)
Delayed graft function	138 (47%)	0	13 (62%)	125 (45%)
Induction regimen
Thymoglobulin antibodies	139 (47%)	0	8 (38%)	131 (48%)
Anti-CD25	154 (52%)	0	13 (62%)	141 (51%)
None	3 (1%)	0	0 (0%)	3 (1%)
Steroid-free regimen	63 (22%)	6	2 (10%)	61 (23%)
Steroids exposure $\ge$ 1 years	116 (40%)	6	11 (52%)	105 (39%)
Transplantation follow-up
Urinary tract infectiona	74/296 (25%)	0	4/21 (19%)	70/275 (25%)
eGFR at 3 mo after kidney transplantation (ml/min per 1.73 m2)	44 (16)	7	43 (18)	44 (5)

ADPKD, autosomal dominant polycystic kidney disease; BMI, body mass index; eGFR, estimated glomerular filtration rate; HLA, human leukocyte antigen; MDRD, modification of diet in renal disease.

Continuous variables were summarized as mean and SD, and categorical and ordinal variables were summarized as frequencies and percentages.

^aExcluding renal cyst infection.